Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001140361-23-010102

President and CEO acquired 324,711 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Touchon Pascal President and CEO 2023-03-01 Grant or award +324,711 766,407 D
Derivatives
Touchon Pascal President and CEO 2023-03-01 Grant or award · Employee Stock Option (Right to Buy) +730,600 730,600 D
Loading xslF345X03/form4.xml…